Itiliti Health adds CEO, CRO ahead of prior authorization mandate

Itiliti Health has named Kevin Aniskovich CEO and Cindy Hommer chief revenue officer as the healthcare software company scales ahead of the CMS-0057 electronic prior authorization deadline on Jan. 1, 2027. Founder Michael Lunzer will stay on as president, focusing on product vision and market strategy.

Why it matters: - Itiliti Health is positioning for faster growth as health plans and Medicaid agencies race to meet the Jan. 1, 2027 CMS-0057 electronic prior authorization mandate. - The leadership changes signal a push to expand the company’s footprint across payer, provider, pharmacy and government workflows. - Prior authorization modernization is becoming a compliance issue as well as an operational one for payers.

What happened: - Itiliti Health named Kevin Aniskovich chief executive officer and Cindy Hommer chief revenue officer. - Michael Lunzer, the company founder, will continue as president. - The company announced the leadership additions July 28, 2026, in Eden Prairie, Minnesota. - Itiliti Health focuses on prior authorization automation and medical policy digitization.

The details: - Aniskovich brings 30 years of experience building healthcare companies in regulated markets. - He previously served as president and CEO of Jumo Health. - He also founded Intelecare Compliance Solutions, which grew to more than 12 million users before a successful exit. - Hommer brings more than 25 years of experience across payer, provider and healthcare technology markets. - Hommer previously held leadership roles at MCG, Medical Review Institute of America, Mercer and UnitedHealth Group. - Hommer’s background includes Medicare, utilization management, care and disease management, behavioral health, value-based care and AI-enabled healthcare solutions. - Lunzer will focus on product vision, market strategy and industry thought leadership. - Itiliti Health serves health plans, BUCA plans, TPAs, delegated vendors and state Medicaid agencies. - The company’s products include PA Checkpoint, Policy Management, Auto Auth, Clinical Decision Assistant and PA Routing. - Those tools are designed to reduce administrative burden, control costs and support CMS-0057 compliance while preserving human clinical review on denial decisions. - The company said its intelligence software has seen rapid adoption among some of the nation’s largest payers.

Between the lines: - The hires suggest Itiliti Health is moving from product development into a broader commercial scale-up phase. - Aniskovich’s background in regulated healthcare and exits points to a focus on growth and market expansion. - Hommer’s payer and utilization management experience aligns with the operational pain points CMS-0057 is meant to address. - Lunzer remaining on product and strategy may help the company keep continuity as it adds senior commercial leadership.

What's next: - Itiliti Health is expected to use the new leadership team to accelerate adoption before the compliance deadline. - The company is also aiming to extend its platform into adjacent workflows beyond prior authorization. - Future growth will likely center on payer modernization, interoperability and AI-enabled use cases unlocked by data connectivity.

The bottom line: - Itiliti Health is betting that compliance pressure around prior authorization will drive a larger market for its automation platform.